Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $9.40 billion. The enterprise value is $8.72 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.29 million shares outstanding. The number of shares has increased by 10.46% in one year.
| Current Share Class | 22.29M |
| Shares Outstanding | 22.29M |
| Shares Change (YoY) | +10.46% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 11.47% |
| Owned by Institutions (%) | 70.85% |
| Float | 10.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.99 |
| Forward PS | 7.82 |
| PB Ratio | 13.46 |
| P/TBV Ratio | 13.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.18.
| Current Ratio | 5.11 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.55 |
Financial Efficiency
Return on equity (ROE) is -36.30% and return on invested capital (ROIC) is -21.57%.
| Return on Equity (ROE) | -36.30% |
| Return on Assets (ROA) | -18.31% |
| Return on Invested Capital (ROIC) | -21.57% |
| Return on Capital Employed (ROCE) | -37.83% |
| Revenue Per Employee | $976,415 |
| Profits Per Employee | -$533,900 |
| Employee Count | 528 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 0.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.29% in the last 52 weeks. The beta is -1.03, so MDGL's price volatility has been lower than the market average.
| Beta (5Y) | -1.03 |
| 52-Week Price Change | +94.29% |
| 50-Day Moving Average | 432.26 |
| 200-Day Moving Average | 344.62 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 277,773 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MDGL had revenue of $515.55 million and -$281.90 million in losses. Loss per share was -$12.82.
| Revenue | 515.55M |
| Gross Profit | 496.37M |
| Operating Income | -309.81M |
| Pretax Income | -281.90M |
| Net Income | -281.90M |
| EBITDA | -308.40M |
| EBIT | -309.81M |
| Loss Per Share | -$12.82 |
Full Income StatementBalance Sheet
The company has $797.02 million in cash and $123.95 million in debt, giving a net cash position of $673.08 million or $30.20 per share.
| Cash & Cash Equivalents | 797.02M |
| Total Debt | 123.95M |
| Net Cash | 673.08M |
| Net Cash Per Share | $30.20 |
| Equity (Book Value) | 695.98M |
| Book Value Per Share | 31.32 |
| Working Capital | 806.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$307.41 million and capital expenditures -$974,000, giving a free cash flow of -$308.39 million.
| Operating Cash Flow | -307.41M |
| Capital Expenditures | -974,000 |
| Free Cash Flow | -308.39M |
| FCF Per Share | -$13.84 |
Full Cash Flow StatementMargins
Gross margin is 96.28%, with operating and profit margins of -60.09% and -54.68%.
| Gross Margin | 96.28% |
| Operating Margin | -60.09% |
| Pretax Margin | -54.68% |
| Profit Margin | -54.68% |
| EBITDA Margin | -59.82% |
| EBIT Margin | -60.09% |
| FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.46% |
| Shareholder Yield | -10.46% |
| Earnings Yield | -3.00% |
| FCF Yield | -3.28% |
Dividend DetailsAnalyst Forecast
The average price target for MDGL is $521.09, which is 23.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $521.09 |
| Price Target Difference | 23.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 84.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 9.73 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.73 |
| Piotroski F-Score | 2 |
